Compare VCEL & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | MQ |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 1996 | 2021 |
| Metric | VCEL | MQ |
|---|---|---|
| Price | $35.76 | $4.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $57.75 | $5.36 |
| AVG Volume (30 Days) | 557.8K | ★ 2.6M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $624,884,000.00 |
| Revenue This Year | $19.40 | $16.89 |
| Revenue Next Year | $18.24 | $16.36 |
| P/E Ratio | $106.89 | ★ N/A |
| Revenue Growth | 16.45 | ★ 23.25 |
| 52 Week Low | $28.95 | $3.70 |
| 52 Week High | $45.97 | $7.04 |
| Indicator | VCEL | MQ |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 56.61 |
| Support Level | $34.26 | $3.84 |
| Resistance Level | $38.48 | $4.46 |
| Average True Range (ATR) | 1.31 | 0.14 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 94.02 | 69.23 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.